Mode
Text Size
Log in / Sign up

Oral cytology shows high sensitivity and specificity for detecting oral epithelial dysplasia in meta-analysis

Oral cytology shows high sensitivity and specificity for detecting oral epithelial dysplasia in meta…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider oral cytology's high sensitivity (93.8%) for dysplasia detection but recognize study limitations.

This meta-analysis of 26 studies evaluated the diagnostic accuracy of oral cytology for detecting oral epithelial dysplasia or worse, analyzing data from 8397 specimens. The analysis used a bivariate random-effects model to pool results across studies, though specific population characteristics and clinical settings were not reported. The primary outcome was diagnostic accuracy for low-grade squamous intraepithelial lesion or worse, with secondary analyses examining accuracy for high-grade lesions and specifically for cytology using Papanicolaou staining.

The pooled sensitivity for detecting oral epithelial dysplasia or worse was 93.8%, with specificity of 87.7%. For high-grade squamous intraepithelial lesion or worse, sensitivity increased to 95.7%. Oral cytology using Papanicolaou staining showed sensitivity of 94.8%. These results represent pooled estimates from multiple studies, though exact numbers of true positives, false positives, and confidence intervals were not reported in the available data.

Safety and tolerability data were not reported in the abstract. Key limitations were not specified, though the authors note that the accuracy of oral cytology remains controversial. The analysis did not report on population demographics, clinical settings, or comparator tests, limiting generalizability to specific patient groups or practice environments.

Oral cytology is used in screening programs for oral cancer, and these findings suggest it has high diagnostic accuracy for detecting epithelial dysplasia. However, clinicians should interpret these results cautiously as they represent pooled estimates from heterogeneous studies with unreported limitations. The evidence supports oral cytology's potential role in detection but does not establish its impact on clinical outcomes or mortality.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: The majority of oral cancers are diagnosed at an advanced stage. It has been demonstrated that the implementation of screening programs reduces mortality rates. Oral cytology is a technique that is used in these programs. However, the accuracy of oral cytology remains controversial. Therefore, the objective of this meta-analysis was to validate the accuracy of oral cytology. METHODS: A literature search was conducted in the PubMed, Embase, and Cochrane Library databases to identify eligible studies. The inclusion criteria were as follows: studies that evaluated the diagnostic accuracy of oral cytology for low-grade squamous intraepithelial lesion or worse. The article incorporated peer-reviewed articles. In addition, studies that provided sufficient data for conducting a meta-analysis were assessed. The meta-analysis was conducted using a bivariate random-effects model. RESULTS: In total, 26 articles comprising 8397 specimens were included in the study. The meta-analysis yielded a pooled sensitivity of 93.8% and a pooled specificity of 87.7% of oral cytology for identifying oral epithelia dysplasia or worse. A subgroup analysis of studies that evaluated oral cytology with Papanicolaou staining demonstrated a pooled sensitivity of 94.8%. The accuracy of oral cytology in detecting high-grade squamous intraepithelial lesion or worse was examined, resulting in a pooled sensitivity of 95.7%. CONCLUSIONS: This meta-analysis indicated that oral cytology exhibited high sensitivity and specificity in detecting oral epithelia dysplasia or worse, with slightly higher sensitivity for high-grade squamous intraepithelial lesion or worse. A notable advantage of using oral cytology with Papanicolaou staining is the potential for enhanced sensitivity.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.